Health-care companies rose amid sales growth optimism. Drug-store chain CVS Health said it has seen complaints of strong push back from patients on its pharmacy-benefit manager's move to favor Novo ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Eli Lilly and Company ( NYSE: LLY) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 8:00 AM ET Lucas E. Montarce - Executive VP & CFO Michael Czapar - Director of Investor ...

“With the semaglutide shortage declared over, Hims now has to transition its model to generate growth from other products ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies ...

The 71st Fortune 500 ranks America’s largest companies by 2024 fiscal year revenue. Key healthcare takeaways from the most recent listing from Fortune, released June 2: 1. The list includes 12 ...

Investors flocked to shares of NRG as the energy supplier boosted capacity. UnitedHealth stock slumped, and the company’s CEO ...

5. In a blow to Eli Lilly’s Zepbound, CVS Caremark chose Novo Nordisk’s Wegovy as the preferred GLP-1 weight loss medication for its largest commercial template formularies. A CVS spokesperson said ...